Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes

Abroad (travel likely)Recruiting

Conditions

Diabetes Mellitus, Type 2 · Cardiovascular Diseases · Diabetic Nephropathy Type 2

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CHUM, Montreal, Quebec, Canada
Contact: Study coordinator (Marie-Renée Guertin, Il, CRA) · marie.renee.guertin.chum@ssss.gouv.qc.ca · 1-514-249-4209
Contact: Study coordinator (Pavel Hamet, MD, PhD) · 1-514-862-2378
ELNA Medical, Montreal, Quebec, Canada
Contact: Study coordinator (Rose-Lyne Allouch, MD) · rallouch@cdllabs.com · 1-514-344-8022

Study leads

Pavel Hamet, MD, PhD
Principal Investigator
CHUM

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Diabetes Mellitus · Overweight · Obesity

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Escondido, United States

Promoting Intergenerational Health in Rural Kentuckians With Diabetes (PIHRK'D)

Diabetes Mellitus, Type 2

Abroad (travel likely)Recruiting

Galveston, United States

Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention

Non-Alcoholic Fatty Liver Disease · Obesity, Morbid · Brown Fat

Abroad (travel likely)Recruiting

Hong Kong, Hong Kong

Relationship Between Glycemic Control and Irisin in Type 2 Diabetic Patients With Sarcopenic or Non-sarcopenic Obesity

Sarcopenia · Obesity · Diabetes Mellitus, Type 2

Abroad (travel likely)Recruiting

Bari, Italy